Skip to Content Facebook Feature Image

ELIS Kindergarten Launches 6-Week "Time Adventure" Summer Program in Ho Chi Minh City

Business

ELIS Kindergarten Launches 6-Week "Time Adventure" Summer Program in Ho Chi Minh City
Business

Business

ELIS Kindergarten Launches 6-Week "Time Adventure" Summer Program in Ho Chi Minh City

2026-05-07 09:58 Last Updated At:10:15

HO CHI MINH CITY, Vietnam, May 7, 2026 /PRNewswire/ -- ELIS (Eye Level Integrated School), a premier international kindergarten located in Thao Dien, District 2, officially announces the opening of its 2026 Summer Program: "Time Adventure."

Targeting children from K1 to K3 (ages 3 to 6), this intensive 6-week program runs from June 29th to August 7th. It is specifically designed to provide an immersive educational experience that integrates STEM, creative arts, and physical development within a unique historical narrative.

  • Weekly Themes: Immersive Project-Based Learning The "Time Adventure" curriculum is structured into weekly modules, allowing students to explore different eras through hands-on activities:
    • The Prehistoric & Ancient Worlds: Dinosaur fossil excavation and pyramid-themed sensory play.
    • The Age of Exploration & Mechanics: Marine navigation with handmade maps and "Junk Art" robotics.
    • Space Odyssey & Future Cities: Solar system modeling and designing a "Smart City" miniature.

  • Competitive Advantage: Extended Full-Day Schedule (08:00 – 17:00) ELIS offers one of the most comprehensive schedules among international kindergartens in Ho Chi Minh City. While typical summer camps conclude in the early afternoon, ELIS operates from 8:00 AM to 5:00 PM. This extended routine provides:

    • Deep-Dive Learning: More time for complex projects and extracurricular activities.
    • Parental Convenience: A reliable full-day solution for working families in the Thao Dien and its surrounding areas.

  • Integrated Field Trips: Real-World Exploration The program enhances classroom learning with weekly excursions to key locations in Ho Chi Minh City, such as the History Museum, the Central Post Office, KidZania, and Jump Arena. Each trip is carefully aligned with the week's educational theme to provide practical context.
  • Enrollment and Early Bird Discount Registration is now open, with an Early Bird discount available for all applications submitted by May 15th. Due to limited capacity and a commitment to maintaining a low teacher-to-student ratio, early enrollment is strongly recommended.

  • Deep-Dive Learning: More time for complex projects and extracurricular activities.
  • Parental Convenience: A reliable full-day solution for working families in the Thao Dien and its surrounding areas.

For more information, detailed curriculum brochures, or registration, please contact ELIS via Zalo or Phone at 0815 550 085.

About ELIS (Eye Level Integrated School): Located in the vibrant community of Thao Dien, ELIS is an international kindergarten dedicated to a holistic approach to early childhood education, combining academic excellence with creative exploration.

** This press release is distributed by PR Newswire through automated distribution system, for which the client assumes full responsibility. **

ELIS Kindergarten Launches 6-Week "Time Adventure" Summer Program in Ho Chi Minh City

ELIS Kindergarten Launches 6-Week "Time Adventure" Summer Program in Ho Chi Minh City

SEOUL, South Korea and SHANGHAI, May 7, 2026 /PRNewswire/ -- Taimei Technology (HK.02576), a leading AI-powered drug clinical development platform company, and C&R Research (A359090), a top-tier CRO in South Korea, signed an enterprise-level strategic partnership agreement, officially launching the development of an AI-based clinical trial operations system.

Under this partnership, C&R Research will deploy Taimei Technology's leading digital infrastructure and AI Agents across multiple clinical trials to automate and enhance trial design and operational workflows. A particular focus will be on data management, where the EDC + iDM Agent combination will be actively adopted. Innovations such as intelligent data capture and governance, AI-driven eCRF generation, and automated test case creation are expected to boost productivity and quality in clinical research.

Leveraging its full-stack AI capabilities, 13 years of industry expertise, and global operational experience, Taimei Technology has deeply focused on the clinical research vertical, and has been among the first to build a comprehensive AI Agent matrix, enabling scenario-based AI applications across the entire clinical research workflow. Key offerings include eCollect (EDC), eBalance (RTSM), eCOA, eCooperate (CTMS), and eArchives (eTMF), iDM Agent, iCTA Agent, iPV Agent; as well as the iMAP intelligent medical analytics platform etc. These products can be flexibly configured to address critical pain points across clinical research—from efficiency to scientific insights—significantly improving trial efficiency and success rates.

The two companies plan to integrate AI-driven operational models with Korea's CRO-centric clinical trial execution system, thereby building a more efficient and intelligent clinical research framework.

Korea has established a mature ecosystem in innovative drug development and clinical execution, with clinical trial activity and participation in global pipelines ranking among the top worldwide. Industry observers believe this partnership goes beyond technology adoption and will serve as a key catalyst for accelerating the AI-driven digital transformation of South Korea's clinical trial landscape.

Moon Tae Yoon, CEO of C&R Research, commented: "As clinical trials become increasingly complex, AI-based data management and operational automation are emerging as essential competitive factors. Through this partnership, we will build a more efficient and innovative clinical execution system."

Zhao Lu, Chairman of Taimei Technology, stated: "This partnership represents an important opportunity to bring the AI clinical operations experience we have accumulated in global markets into South Korea. We look forward to collaborating with more Korean ecosystem partners to continuously drive the intelligent transformation of clinical trials."

** This press release is distributed by PR Newswire through automated distribution system, for which the client assumes full responsibility. **

Taimei Technology and C&R Research Announce Strategic Partnership to Build AI-Powered Clinical Trial Innovation

Taimei Technology and C&R Research Announce Strategic Partnership to Build AI-Powered Clinical Trial Innovation

Recommended Articles